NCT04730024Not yet recruiting
Long-term Follow-up Study to Evaluate the Safety and Explore the Efficacy of Multiple Doses of FURESTEM-AD Inj
Long-term Follow-up Study to Evaluate the Safety and Explore the Efficacy of Multiple Doses of FURESTEM-AD Inj. for Moderate to Severe Chronic Atopic Dermatitis: 5-year Results From the K0104 Extension Study
Source: ClinicalTrials.gov · Last updated 29 Jan 2021 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
A multi-center, open, long-term follow-up study to Evaluate the Safety and Explore the Efficacy of Multiple Doses of FURESTEM-AD inj. for Moderate to Severe Chronic Atopic Dermatitis: 5-year Results from the K0104 Extension Study
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 102 (estimated)
- First submitted
- 25 Jan 2021
- Start date
- 27 Mar 2022
- Primary completion date
- 30 Jun 2030
- Lead sponsor
- Kang Stem Biotech Co., Ltd.
- Diseases
- Atopic dermatitis (eczema)
- NCT number
- NCT04730024
What you commit to
- Study type: Observational
- Planned participants: 102
- From 27 Mar 2022 to the primary completion date, 30 Jun 2030
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Subjects who has received/administered clinical trial drugs or medical devices by participating in other clinical trials until the first visit of this trial (K0104-E) after the completion of K0104 clinical trial
Other
- Subjects who are expected to be unable to perform at least one follow-up during this study (K0104-E)
- Subjects who are judged to be unsuitable for other researchers to participate in the research
Who the study is looking for
- Subject who enrolled K0104 Clinical Trial(parent study).
- Subjects who understand and voluntarily sign an informed consent form
Age in the registry: 19 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| dongguk University Medical Center Coordinator of this site? Confirm its status | Ilsan | South Korea | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.